Infertility Treatment Market Size, Share, Competitive Landscape and Trend Analysis Report by Procedure, Patient Type, End User, and Region: Global Opportunity Analysis and Industry Forecast, 2024-2033

The infertility treatment market was valued at $1.8 billion in 2023 and is estimated to reach $4.1 billion by 2033, exhibiting a CAGR of 8.4% from 2024 to 2033.

Market Introduction

Infertility, a challenging medical condition affecting numerous couples globally, is defined as the inability to conceive after a year of regular, unprotected intercourse. However, for some couples, the cause remains elusive, leading to what is termed unexplained infertility. The journey towards diagnosing infertility often involves a comprehensive assessment by healthcare professionals who examine the couple's sexual habits and medical history. This assessment may include uncomfortable and sometimes invasive procedures, adding emotional and financial strain to an already difficult situation. Tests for male infertility primarily focus on evaluating the production and health of sperm, encompassing semen analysis, hormone testing, genetic screening, testicular biopsy, and imaging. Conversely, diagnosing female infertility involves examining ovulation, the condition of the reproductive tract, and ovarian reserve through various tests such as ovulation testing, hysterosalpingography, hormone assays, and pelvic imaging. Rarely, more invasive procedures like hysteroscopy and laparoscopy may be necessary to discover underlying issues such as uterine abnormalities or endometriosis.

Key Takeaways

• The infertility treatment market study covers 20 countries. The research includes a segment analysis of each country in terms of value ($billion) for the projected period from 2024 to 2033.
• More than 1,500 product literatures, industry releases, annual reports, and other such documents of major infertility treatment industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
• The study integrates high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach intends to provide a balanced view of global markets and assist stakeholders in making informed decisions in order to achieve their most ambitious growth objectives.

Industry Trends

• On May 18, 2024, Future Generali India introduced ‘HEALTH POWHER,’ a women's health insurance plan catering to diverse needs. With increased limits for female cancer treatment, coverage for infertility treatment, and oocyte cryopreservation, the policy addresses puberty, menopause-related disorders, and mental well-being. Other benefits include stem cell storage, newborn defect lump sum, and senior care. This initiative aims to bridge the gap in healthcare coverage for Indian women, addressing their specific health needs. In addition, value-added services like psychological counseling and fitness programs enhance preventative care.
• On May 16, 2024, May Health, a startup focusing on women's health, secured $25 million in funding to advance its innovative approach to treating infertility caused by polycystic ovary syndrome (PCOS). The company's ‘ovarian rebalancing’ procedure aims to restore natural ovulation cycles, offering hope to millions of women affected by PCOS.
• On May 14, 2024, due to rise in demand for infertility treatment in Washington state, Reproductive Medicine Associates (RMA) expanded its services to Bellevue. With an estimated 200,000 people affected by infertility in the state, RMA's new clinic aims to improve access for patients, particularly those on the Eastside and in Eastern Washington.
• On March 26, 2024, 'NaPro technology' emerged as a pro-life alternative for infertility treatment. Unlike IVF, NaPro focuses on treating underlying causes, monitoring fertility cycles, and restoring natural reproductive function.

Key Market Dynamics

The demand for infertility treatment is witnessing a significant rise due to factors like increased awareness and acceptance of IVF, and a surge in infertility cases attributed to lifestyle changes. The drivers for infertility treatment are majorly attributed to the staggering prevalence of infertility worldwide, affecting approximately 17.5% of the adult population. Restraints to infertility treatment include financial barriers, limited access to specialized care, and social stigma surrounding fertility issues. Many individuals and couples face significant financial burdens due to the high costs of fertility treatments, which are often not covered by insurance. Opportunities in infertility treatment specially in the IVF sector in India lie in enhanced awareness, education, and affordability. Collaborative efforts to educate the public about fertility treatments can expand the reach of IVF to more couples in need. Innovations aimed at reducing costs and improving accessibility can make IVF more inclusive. In addition, advancements in genetic screening and personalized treatments offer prospects for further increasing success rates.

Global Infertility Treatment Market Ecosystem Analysis

Infertility is a complex issue affecting millions worldwide, characterized by the inability to conceive after a year of regular, unprotected intercourse. Causes can stem from various factors impacting both partners.

In men, conditions like hormonal imbalances, genetic defects, and infections may hinder sperm production or impair their function. Environmental factors such as exposure to toxins or radiation can also be a factor.

For women, ovulation disorders, uterine abnormalities, and fallopian tube damage are common causes. Endometriosis, pelvic inflammatory disease, and primary ovarian insufficiency further contribute to female infertility.

Lifestyle factors like tobacco and alcohol use, obesity, and extremes of exercise can worsen fertility challenges for both sexes.

In addition, advancing age significantly affects fertility, with women experiencing a decline in egg quality and quantity, while men may face reduced sperm quality and quantity. Awareness regarding these diverse causes highlights the importance of comprehensive evaluation and tailored interventions in addressing infertility effectively.

Following were the Major Causes of Infertility in 2021

Market Segmentation

The infertility treatment market is segmented into procedure, patient type, end user, and region. On the basis of procedure, the market is divided into assisted reproductive technology, artificial insemination, fertility surgeries, and other procedures. On the basis of patient type, the market is classified into female infertility treatment and male infertility treatment. On the basis of end user, the market is divided into fertility centers, hospitals & surgical clinics, cryobanks, and research institutes. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Country Market Outlook

In the U.S., infertility is a widespread issue affecting millions of individuals, with approximately 9% of women aged 15 to 49 experiencing some form of infertility. Moreover, about 9% of men aged 15 to 44 also faced infertility challenges in 2021.

Assisted Reproductive Technology (ART) use in the U.S., in 2021 is as follows:

* National data based on 413,776 ART cycles.

^a National data based on 202,054 ART cycles in which at least one embryo was transferred.

ART: Assisted Reproductive Technology

Source: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Reproductive Health. Assisted Reproductive Technology (ART) Data, Patient and Cycle Characteristics.

Competitive Landscape

The major players operating in the infertility treatment market include Thermo Fisher Scientific, Vitrolife, Cook Group, Hamilton Thorne Ltd., IVFtech APS, FUJIFILM Irvine Scientific, Esco Micro Pte Ltd., Genea Biomedx Ltd., Baker Company INC., and others.

Recent Key Strategies and Developments

• In December 2023, Indira IVF teamed up with SafeTree to introduce India's inaugural infertility insurance plan. This initiative aims to assist couples experiencing infertility by providing comprehensive support, including medical, dietary, and psychological consultations over a proactive 24-month period. Targeting couples under 35, the plan emphasizes natural conception, offering cashless coverage for two rounds of IUI and IVF treatments if needed. SafeTree extends coverage to egg donors and surrogates, adhering to relevant regulations. The partnership also promises further developments in fertility assessment tools and insurance products, backed by a panel of experts in the field.
• In July 2023, Korean researchers devised a hydrogel that can revolutionize female infertility treatment. This breakthrough, led by a team from POSTECH and CHA University, utilizes a uterus-derived decellularized extracellular matrix (UdECM) to regenerate the endometrium, crucial for successful pregnancies. Published in Advanced Functional Materials, the study unveils the mechanism behind endometrial regeneration, highlighting the involvement of insulin-like growth factor (IGF1) and insulin growth factor-binding protein (IGFBP3). With low cytotoxicity and therapeutic effects against various conditions, this hydrogel holds promise for personalized infertility treatments.

Key Sources Referred

1. National Institutes of Health (NIH)
2. World Health Organization (WHO)
3. U.S. Department of Health & Human Services
4. Cleveland Clinic
5. Society of Reproductive Surgeons (SRS)

Key Benefits for Stakeholders

• This report provides a quantitative analysis of the infertility treatment market segments, current trends, estimations, and dynamics of the infertility treatment market analysis from 2023 to 2033 to identify the prevailing infertility treatment market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the infertility treatment market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global infertility treatment market statistics.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global infertility treatment market trends, key players, market segments, application areas, and market growth strategies.

In addition to providing a detailed analysis of key players in the global market, the report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.

1. Research Methodology

1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation

1.5.1. Top-down approach
1.5.2. Bottom-up approach

2. Report Scope

2.1. Market Definition
2.2. Key objectives of the study
2.3. Market segmentation

3. Executive Summary
4. Market Overview

4.1. Introduction
4.2. Growth impact forces

4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities

4.3. Market value chain analysis

4.3.1. List of suppliers
4.3.2. List of manufacturers 
4.3.3. List of distributors

4.4. Innovation & sustainability matrices

4.4.1. Technology matrix
4.4.2. Regulatory matrix

4.5. Porter’s five forces analysis

4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive Rivalry Intensity

4.6. PESTLE analysis

4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Legal
4.6.6. Environmental

4.7. Impact of COVID-19 on the Infertility Treatment Market

4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario

5. Infertility Treatment Market Analysis, by Procedure

5.1. Overview
5.2. Assisted Reproductive Technology  

5.2.1. Definition, key trends, growth factors, and opportunities
5.2.2. Market size analysis, by region, 2023-2033
5.2.3. Market share analysis, by country, 2023-2033

5.3. Artificial Insemination

5.3.1. Definition, key trends, growth factors, and opportunities
5.3.2. Market size analysis, by region, 2023-2033
5.3.3. Market share analysis, by country, 2023-2033

5.4. Fertility Surgeries

5.4.1. Definition, key trends, growth factors, and opportunities
5.4.2. Market size analysis, by region, 2023-2033
5.4.3. Market share analysis, by country, 2023-2033

5.5. Other Procedures

5.5.1. Definition, key trends, growth factors, and opportunities
5.5.2. Market size analysis, by region, 2023-2033
5.5.3. Market share analysis, by country, 2023-2033

5.6. Research Dive Exclusive Insights

5.6.1. Market attractiveness
5.6.2. Competition heatmap

6. Infertility Treatment Market Analysis, by Patient Type

6.1. Overview
6.2. Female Infertility Treatment

6.2.1. Definition, key trends, growth factors, and opportunities
6.2.2. Market size analysis, by region, 2023-2033
6.2.3. Market share analysis, by country, 2023-2033

6.3. Male Infertility Treatment

6.3.1. Definition, key trends, growth factors, and opportunities
6.3.2. Market size analysis, by region, 2023-2033
6.3.3. Market share analysis, by country, 2023-2033

6.4. Research Dive Exclusive Insights

6.4.1. Market attractiveness
6.4.2. Competition heatmap

7. Infertility Treatment Market Analysis, by End User

7.1. Overview
7.2. Fertility Centers

7.2.1. Definition, key trends, growth factors, and opportunities
7.2.2. Market size analysis, by region, 2023-2033
7.2.3. Market share analysis, by country, 2023-2033

7.3. Hospitals & Surgical Clinics

7.3.1. Definition, key trends, growth factors, and opportunities
7.3.2. Market size analysis, by region, 2023-2033
7.3.3. Market share analysis, by country, 2023-2033

7.4. Cryobanks

7.4.1. Definition, key trends, growth factors, and opportunities
7.4.2. Market size analysis, by region, 2023-2033
7.4.3. Market share analysis, by country, 2023-2033

7.5. Research Institutes 

7.5.1. Definition, key trends, growth factors, and opportunities
7.5.2. Market size analysis, by region, 2023-2033
7.5.3. Market share analysis, by country, 2023-2033

7.6. Research Dive Exclusive Insights

7.6.1. Market attractiveness
7.6.2. Competition heatmap

8. Infertility Treatment Market, by Region

8.1. North America

8.1.1. U.S.

8.1.1.1. Market size analysis, by Procedure, 2023-2033
8.1.1.2. Market size analysis, by Patient Type, 2023-2033
8.1.1.3. Market size analysis, by End User, 2023-2033

8.1.2. Canada

8.1.2.1. Market size analysis, by Procedure, 2023-2033
8.1.2.2. Market size analysis, by Patient Type, 2023-2033
8.1.2.3. Market size analysis, by End User, 2023-2033

8.1.3. Mexico

8.1.3.1. Market size analysis, by Procedure, 2023-2033
8.1.3.2. Market size analysis, by Patient Type, 2023-2033
8.1.3.3. Market size analysis, by End User, 2023-2033

8.1.4. Research Dive Exclusive Insights

8.1.4.1. Market attractiveness
8.1.4.2. Competition heatmap

8.2. Europe

8.2.1. Germany 

8.2.1.1. Market size analysis, by Procedure, 2023-2033
8.2.1.2. Market size analysis, by Patient Type, 2023-2033
8.2.1.3. Market size analysis, by End User, 2023-2033

8.2.2. UK

8.2.2.1. Market size analysis, by Procedure, 2023-2033
8.2.2.2. Market size analysis, by Patient Type, 2023-2033
8.2.2.3. Market size analysis, by End User, 2023-2033

8.2.3. France

8.2.3.1. Market size analysis, by Procedure, 2023-2033
8.2.3.2. Market size analysis, by Patient Type, 2023-2033
8.2.3.3. Market size analysis, by End User, 2023-2033

8.2.4. Spain

8.2.4.1. Market size analysis, by Procedure, 2023-2033
8.2.4.2. Market size analysis, by Patient Type, 2023-2033
8.2.4.3. Market size analysis, by End User, 2023-2033

8.2.5. Italy

8.2.5.1. Market size analysis, by Procedure, 2023-2033
8.2.5.2. Market size analysis, by Patient Type, 2023-2033
8.2.5.3. Market size analysis, by End User, 2023-2033

8.2.6. Rest of Europe

8.2.6.1. Market size analysis, by Procedure, 2023-2033
8.2.6.2. Market size analysis, by Patient Type, 2023-2033
8.2.6.3. Market size analysis, by End User, 2023-2033

8.2.7. Research Dive Exclusive Insights

8.2.7.1. Market attractiveness
8.2.7.2. Competition heatmap

8.3. Asia-Pacific

8.3.1. China

8.3.1.1. Market size analysis, by Procedure, 2023-2033
8.3.1.2. Market size analysis, by Patient Type, 2023-2033
8.3.1.3. Market size analysis, by End User, 2023-2033

8.3.2. Japan 

8.3.2.1. Market size analysis, by Procedure, 2023-2033
8.3.2.2. Market size analysis, by Patient Type, 2023-2033
8.3.2.3. Market size analysis, by End User, 2023-2033

8.3.3. India

8.3.3.1. Market size analysis, by Procedure, 2023-2033
8.3.3.2. Market size analysis, by Patient Type, 2023-2033
8.3.3.3. Market size analysis, by End User, 2023-2033

8.3.4. Australia

8.3.4.1. Market size analysis, by Procedure, 2023-2033
8.3.4.2. Market size analysis, by Patient Type, 2023-2033
8.3.4.3. Market size analysis, by End User, 2023-2033

8.3.5. South Korea

8.3.5.1. Market size analysis, by Procedure, 2023-2033
8.3.5.2. Market size analysis, by Patient Type, 2023-2033
8.3.5.3. Market size analysis, by End User, 2023-2033

8.3.6. Rest of Asia-Pacific

8.3.6.1. Market size analysis, by Procedure, 2023-2033
8.3.6.2. Market size analysis, by Patient Type, 2023-2033
8.3.6.3. Market size analysis, by End User, 2023-2033

8.3.7. Research Dive Exclusive Insights

8.3.7.1. Market attractiveness
8.3.7.2. Competition heatmap

8.4. LAMEA

8.4.1. Brazil

8.4.1.1. Market size analysis, by Procedure, 2023-2033
8.4.1.2. Market size analysis, by Patient Type, 2023-2033
8.4.1.3. Market size analysis, by End User, 2023-2033

8.4.2. UAE

8.4.2.1. Market size analysis, by Procedure, 2023-2033
8.4.2.2. Market size analysis, by Patient Type, 2023-2033
8.4.2.3. Market size analysis, by End User, 2023-2033

8.4.3. Saudi Arabia

8.4.3.1. Market size analysis, by Procedure, 2023-2033
8.4.3.2. Market size analysis, by Patient Type, 2023-2033
8.4.3.3. Market size analysis, by End User, 2023-2033

8.4.4. South Africa

8.4.4.1. Market size analysis, by Procedure, 2023-2033
8.4.4.2. Market size analysis, by Patient Type, 2023-2033
8.4.4.3. Market size analysis, by End User, 2023-2033

8.4.5. Rest of LAMEA

8.4.5.1. Market size analysis, by Procedure, 2023-2033
8.4.5.2. Market size analysis, by Patient Type, 2023-2033
8.4.5.3. Market size analysis, by End User, 2023-2033

8.4.6. Research Dive Exclusive Insights

8.4.6.1. Market attractiveness
8.4.6.2. Competition heatmap

9. Competitive Landscape

9.1. Top winning strategies, 2023

9.1.1. By strategy
9.1.2. By year

9.2. Strategic overview
9.3. Market share analysis, 2023

10. Company Profiles

10.1. Thermo Fisher Scientific

10.1.1. Overview
10.1.2. Business segments
10.1.3. Product portfolio
10.1.4. Financial performance
10.1.5. Recent developments
10.1.6. SWOT analysis

10.2. Vitrolife

10.2.1. Overview
10.2.2. Business segments
10.2.3. Product portfolio
10.2.4. Financial performance
10.2.5. Recent developments
10.2.6. SWOT analysis

10.3. Cook Group

10.3.1. Overview
10.3.2. Business segments
10.3.3. Product portfolio
10.3.4. Financial performance
10.3.5. Recent developments
10.3.6. SWOT analysis

10.4. Hamilton Thorne Ltd.

10.4.1. Overview
10.4.2. Business segments
10.4.3. Product portfolio
10.4.4. Financial performance
10.4.5. Recent developments
10.4.6. SWOT analysis

10.5. IVFtech APS

10.5.1. Overview
10.5.2. Business segments
10.5.3. Product portfolio
10.5.4. Financial performance
10.5.5. Recent developments
10.5.6. SWOT analysis

10.6. FUJIFILM Irvine Scientific

10.6.1. Overview
10.6.2. Business segments
10.6.3. Product portfolio
10.6.4. Financial performance
10.6.5. Recent developments
10.6.6. SWOT analysis

10.7. Esco Micro Pte Ltd.

10.7.1. Overview
10.7.2. Business segments
10.7.3. Product portfolio
10.7.4. Financial performance
10.7.5. Recent developments
10.7.6. SWOT analysis

10.8. Genea Biomedx Ltd.

10.8.1. Overview
10.8.2. Business segments
10.8.3. Product portfolio
10.8.4. Financial performance
10.8.5. Recent developments
10.8.6. SWOT analysis

10.9. Baker Company INC.

10.9.1. Overview
10.9.2. Business segments
10.9.3. Product portfolio
10.9.4. Financial performance
10.9.5. Recent developments
10.9.6. SWOT analysis

* Taxes/Fees, If applicable will be added during checkout. All prices in USD.